Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996 Aug;39(2):194-8.
doi: 10.1136/gut.39.2.194.

Prophylactic administration of L-arginine improves the intestinal barrier function after mesenteric ischaemia

Affiliations
Comparative Study

Prophylactic administration of L-arginine improves the intestinal barrier function after mesenteric ischaemia

R Schleiffer et al. Gut. 1996 Aug.

Abstract

Background: Ischaemia/reperfusion (I/R) of the intestine causes mucosal injury associated with a high death rate in rats.

Aim: To investigate whether nitric oxide (NO) might be implicated in the recovery of the intestinal mucosa after ischaemic insult.

Methods: Wistar rats were subjected to mesenteric artery occlusion for 90 minutes. The animals were given either L-arginine, the substrate of NO synthase, or molsidomine, a NO donor. The controls received casein hydrolysate. The compounds were administered by gavage 19, 16, and 1.5 hours before ischaemia. Mucosal barrier permeability and cGMP content were determined 24 hours after ischaemia.

Results: Survival after I/R was 50% in the control group. Animals treated with L-arginine or molsidomine exhibited a higher survival rate (70% and 83% respectively). Mucosal barrier permeability was decreased in rats receiving L-arginine or molsidomine compared with controls (4.0 (0.9) and 2.6 (0.6) v 11.2 (1.6) 14C-PEG pmol/segment, p < 0.05). Increased cGMP content was seen in the mucosa of the L-arginine group.

Conclusion: The findings suggest that pretreatment with L-arginine or molsidomine ameliorates survival after intestinal I/R and improves mucosal barrier function.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 1988 Jun 16;333(6174):664-6 - PubMed
    1. Gut. 1988 Apr;29(4):489-94 - PubMed
    1. Surgery. 1989 May;105(5):593-7 - PubMed
    1. Am J Physiol. 1989 Sep;257(3 Pt 1):G409-14 - PubMed
    1. J Clin Invest. 1989 Nov;84(5):1373-8 - PubMed

Publication types

MeSH terms